These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30680790)

  • 1. Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients.
    Rayner JE; McMeniman EK; Duffy DL; De'Ambrosis B; Smithers BM; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1076-1083. PubMed ID: 30680790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.
    Rayner JE; Duffy DL; Smit DJ; Jagirdar K; Lee KJ; De'Ambrosis B; Smithers BM; McMeniman EK; McInerney-Leo AM; Schaider H; Stark MS; Soyer HP; Sturm RA
    PLoS One; 2020; 15(9):e0238529. PubMed ID: 32966289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological, dermoscopic features and circumstances of diagnosis of amelanotic or hypomelanotic melanoma: A prospective multicentric study in the French private medical sector.
    Lorier Roy E; Gourhant JY; Derancourt C; Jouan N; Dupuy A; Séi JF;
    Ann Dermatol Venereol; 2024 Mar; 151(1):103249. PubMed ID: 38422599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More than one shade of pink as a marker of early amelanotic/hypomelanotic melanoma.
    Pizzichetta MA; Corsetti P; Stanganelli I; Ghigliotti G; Cavicchini S; De Giorgi V; Bono R; Astorino S; Ribero S; Argenziano G; Alaibac ; Polesel J;
    J Dermatol; 2024 Jul; 51(7):999-1003. PubMed ID: 39412946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelanotic/Hypomelanotic melanoma--is dermatoscopy useful for diagnosis?
    Zalaudek I; Argenziano G; Kerl H; Soyer HP; Hofmann-Wellenhof R
    J Dtsch Dermatol Ges; 2003 May; 1(5):369-73. PubMed ID: 16285302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatoscopy of amelanotic and hypomelanotic melanoma.
    Stojkovic-Filipovic J; Kittler H
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):467-72. PubMed ID: 24825465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelanotic melanoma.
    Gong HZ; Zheng HY; Li J
    Melanoma Res; 2019 Jun; 29(3):221-230. PubMed ID: 30672881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study.
    Paolino G; Bearzi P; Pampena R; Longo C; Frascione P; Rizzo N; Raucci M; Carbone A; Cantisani C; Ricci F; Didona D; Frattini F; Bulotta A; Gregorc V; Mercuri SR
    Int J Dermatol; 2020 Nov; 59(11):1371-1380. PubMed ID: 32726478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants.
    Choi ME; Choi EJ; Lee JH; Won CH; Chang SE; Lee MW; Lee WJ
    Br J Dermatol; 2024 Sep; 191(4):580-591. PubMed ID: 38815138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF and KIT somatic mutations are present in amelanotic melanoma.
    Massi D; Pinzani P; Simi L; Salvianti F; De Giorgi V; Pizzichetta MA; Mirri F; Steffan A; Orlando C; Santucci M; Canzonieri V
    Melanoma Res; 2013 Oct; 23(5):414-9. PubMed ID: 23938765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
    Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma.
    Pouryazdanparast P; Brenner A; Haghighat Z; Guitart J; Rademaker A; Gerami P
    Mod Pathol; 2012 Sep; 25(9):1221-6. PubMed ID: 22555175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features.
    Paolino G; Pampena R; Di Ciaccio SM; Carugno A; Cantisani C; Di Nicola MR; Losco L; Bortone G; Mercuri SR; Costanzo A; Ardigò M; Valenti M
    Medicina (Kaunas); 2024 Jul; 60(8):. PubMed ID: 39202520
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermoscopic clues in the diagnosis of amelanotic and hypomelanotic malignant melanoma.
    Steglich RB; Meotti CD; Ferreira MS; Lovatto L; de Carvalho AV; de Castro CG
    An Bras Dermatol; 2012; 87(6):920-3. PubMed ID: 23197217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.